Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

11.29
-0.5500-4.65%
Volume:162.58K
Turnover:1.88M
Market Cap:153.54M
PE:-2.82
High:11.95
Open:11.93
Low:11.25
Close:11.84
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:0.57
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.20
PE(LYR):-1.81

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

B. Riley Adjusts Price Target on Immunic to $27 From $40, Maintains Buy Rating

MT Newswires Live
·
May 22

Immunic director Michael W. Bonney files initial beneficial ownership statement

Reuters
·
May 20

Immunic names Michael Bonney board chair, replacing interim chair Simona Skerjanec

Reuters
·
May 19

Immunic Inc - Simona Skerjanec Transitions From Interim Chairperson to Board Member

THOMSON REUTERS
·
May 19

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

THOMSON REUTERS
·
May 19

Immunic (IMUX) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 18

Immunic price target lowered to $19 from $26 at Roth Capital

TIPRANKS
·
May 14

Immunic (IMUX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 14

Immunic Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Immunic Q1 EPS $(1.08) Misses $(0.91) Estimate

Benzinga Earnings
·
May 13

Immunic Q1 Basic EPS USD -1.08

THOMSON REUTERS
·
May 13

Immunic Q1 FY26 net loss widens to $32.6 million

Reuters
·
May 13

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Immunic Inc expected to post a loss of 91 cents a share - Earnings Preview

Reuters
·
May 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
May 06

Immunic Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Immunic attends Bio€quity Europe investor conference in May

Reuters
·
Apr 30

Immunic price target adjusted to $22 from $5 at H.C. Wainwright

TIPRANKS
·
Apr 30

Immunic files Form 3 for Chief Medical Officer Michael A. Panzara

Reuters
·
Apr 29